Roberto Soler

Suggest Changes

Writes About:

Learn More
AIMS Beta3-adrenoceptor selective agonists are evaluated as a new treatment for patients with lower urinary tract symptoms . It is believed that β3-AR selective agonists exert their effects via a(More)